Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

685 public trials 115 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.

NCT00078000

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Pfizer Investigational Site Greenbrae, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site San Francisco, California, United States
  • Pfizer Investigational Site Aurora, Colorado, United States
View Trial Details
Completed

Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine

NCT00072852

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Pfizer Investigational Site Mobile, Alabama, United States
  • Pfizer Investigational Site Anchorage, Alaska, United States
  • Pfizer Investigational Site Lewistown, Idaho, United States
  • Pfizer Investigational Site Alton, Illinois, United States
View all 66 locations
View Trial Details
Completed

A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer

NCT00649090

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Pfizer Investigational Site Aalst, Belgium
  • Pfizer Investigational Site Antwerp, Belgium
  • Pfizer Investigational Site Arlon, Belgium
  • Pfizer Investigational Site Baudour, Belgium
View all 61 locations
View Trial Details
Completed

Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy

NCT00386087

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Newark, Delaware, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. South Bend, Indiana, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boston, Massachusetts, United States
View Trial Details

Related conditions